MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
149
Unique beneficiaries
—
Total services
245
Distinct HCPCS
6
Medicare payment
$17K
Peer benchmark
Total Medicare services vs. 165 Endocrinology providers in VA — bottom quintile (cohort median 1,021).
PRESCRIBING · PART D · 2024
Total Rx claims
446
Beneficiaries
—
Total drug cost
$98K
Distinct drugs
14
Brand share
39.0%
Top prescribed drugs
Insulin Glargine,hum.Rec.Anlog64 claims
Empagliflozin50 claims
Hydrochlorothiazide44 claims
Lisinopril39 claims
Atorvastatin Calcium36 claims
QUALITY · MIPS · 2024
Final MIPS score
86.5
Quality
79.8
Cost
75.1
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.48%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
CROSS-REFERENCE